DayTwo pulls in $31 mln Series B
Israel-based DayTwo, a microbiome human discovery platform, has secured $31 million in Series B financing. The lead investors were aMoon and Ofek Ventures.
26 June 2019•1 min read
Israel-based DayTwo, a microbiome human discovery platform, has secured $31 million in Series B financing. The lead investors were aMoon and Ofek Ventures.
